{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:27:44Z","timestamp":1787689664972,"version":"build-2784847793"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"vor","delay-in-days":288,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","award":["7640"],"award-info":[{"award-number":["7640"]}],"id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Informatics in Medicine Unlocked"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.imu.2020.100458","type":"journal-article","created":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T11:20:46Z","timestamp":1602933646000},"page":"100458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Applying computer simulations in battling with COVID-19, using pre-analyzed molecular and chemical data to face the pandemic"],"prefix":"10.1016","volume":"21","author":[{"given":"Mohammad Amin","family":"Khazeei Tabari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hooman","family":"Khoshhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Tafazoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohanna","family":"Khandan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abouzar","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.imu.2020.100458_bib1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrmicro2147","article-title":"Coronaviruses post-SARS: update on replication and pathogenesis","volume":"7","author":"Perlman","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.imu.2020.100458_bib2","series-title":"StatPearlsTreasure Island (FL)","article-title":"Features, evaluation and treatment coronavirus (COVID-19)","author":"Cascella","year":"2020"},{"key":"10.1016\/j.imu.2020.100458_bib3","doi-asserted-by":"crossref","unstructured":"H. M. Ashour, W. F. Elkhatib, M. M. Rahman, and H. A. Elshabrawy, \"Insights into the recent 2019 novel coronavirus (SARS-CoV-2) in light of past human coronavirus outbreaks,\" (in eng), Pathogens, vol. 9, no. 3, Mar 4 2020.","DOI":"10.3390\/pathogens9030186"},{"issue":"5","key":"10.1016\/j.imu.2020.100458_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00187-20","article-title":"The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options","volume":"58","author":"Khan","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.imu.2020.100458_bib5","series-title":"Epidemic analysis of COVID-19 in China by dynamical modeling","author":"Peng","year":"2020"},{"key":"10.1016\/j.imu.2020.100458_bib6","first-page":"1","article-title":"How could artificial intelligence aid in the fight against coronavirus?","author":"Yassine","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.imu.2020.100458_bib7","series-title":"StatPearls [Internet]","article-title":"Features, evaluation and treatment coronavirus (COVID-19)","author":"Cascella","year":"2020"},{"issue":"1","key":"10.1016\/j.imu.2020.100458_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan","volume":"9","author":"Chan","year":"2020","journal-title":"Emerg Microb Infect"},{"issue":"4\u20135","key":"10.1016\/j.imu.2020.100458_bib9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.micinf.2020.04.002","article-title":"Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses","volume":"22","author":"Tilocca","year":"2020","journal-title":"Microb Infect"},{"issue":"9","key":"10.1016\/j.imu.2020.100458_bib10","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/jmv.25751","article-title":"Identification of coronavirus sequences in carp cDNA from Wuhan, China","volume":"92","author":"Conway","year":"2020","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.imu.2020.100458_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.imu.2020.100458_bib12","doi-asserted-by":"crossref","first-page":"W252","DOI":"10.1093\/nar\/gku340","article-title":"SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information","volume":"42","author":"Biasini","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.imu.2020.100458_bib13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.imu.2020.100458_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41421-020-0147-1","article-title":"Comparative genetic analysis of the novel coronavirus (2019-nCoV\/SARS-CoV-2) receptor ACE2 in different populations","volume":"6","author":"Cao","year":"2020","journal-title":"Cell Discov"},{"issue":"8","key":"10.1016\/j.imu.2020.100458_bib15","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/sj.emboj.7600640","article-title":"Receptor and viral determinants of SARS\u2010coronavirus adaptation to human ACE2","volume":"24","author":"Li","year":"2005","journal-title":"EMBO J"},{"issue":"6965","key":"10.1016\/j.imu.2020.100458_bib16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.imu.2020.100458_bib17","first-page":"410","article-title":"Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: an in silico analysis","volume":"19","author":"Ortega","year":"2020","journal-title":"EXCLI J"},{"issue":"4","key":"10.1016\/j.imu.2020.100458_bib18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.chom.2020.03.002","article-title":"A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2","volume":"27","author":"Grifoni","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.imu.2020.100458_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12985-019-1182-0","article-title":"Coronavirus envelope protein: current knowledge","volume":"16","author":"Schoeman","year":"2019","journal-title":"Virol J"},{"key":"10.1016\/j.imu.2020.100458_bib20","first-page":"1","article-title":"In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel","author":"Gupta","year":"2020","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.imu.2020.100458_bib21","doi-asserted-by":"crossref","first-page":"4389089","DOI":"10.1155\/2020\/4389089","article-title":"Sars-CoV-2 envelope and membrane proteins: structural differences linked to virus characteristics?","author":"Bianchi","year":"2020","journal-title":"BioMed Res Int"},{"issue":"2","key":"10.1016\/j.imu.2020.100458_bib22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.virol.2006.01.028","article-title":"Biochemical and functional characterization of the membrane association and membrane permeabilizing activity of the severe acute respiratory syndrome coronavirus envelope protein","volume":"349","author":"Liao","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.imu.2020.100458_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0065-3527(05)64006-7","article-title":"Molecular interactions in the assembly of coronaviruses","volume":"64","author":"de Haan","year":"2005","journal-title":"Adv Virus Res"},{"issue":"2","key":"10.1016\/j.imu.2020.100458_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.virol.2008.06.038","article-title":"Proteolytic processing of polyproteins 1a and 1ab between non-structural proteins 10 and 11\/12 of Coronavirus infectious bronchitis virus is dispensable for viral replication in cultured cells","volume":"379","author":"Fang","year":"2008","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.imu.2020.100458_bib25","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/jmv.25761","article-title":"The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase","volume":"92","author":"Lung","year":"2020","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.imu.2020.100458_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3855\/jidc.12425","article-title":"2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness","volume":"14","author":"Ralph","year":"2020","journal-title":"J Infect Dev Ctries"},{"issue":"4","key":"10.1016\/j.imu.2020.100458_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jpha.2020.03.009","article-title":"Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants","volume":"10","author":"Tahir ul Qamar","year":"2020","journal-title":"J Pharmaceut Anal"},{"issue":"1","key":"10.1016\/j.imu.2020.100458_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1021\/np0502600","article-title":"Isoflavonoids and other compounds from Psorothamnus a rborescens with antiprotozoal activities","volume":"69","author":"Salem","year":"2006","journal-title":"J Nat Prod"},{"issue":"2","key":"10.1016\/j.imu.2020.100458_bib29","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.joim.2020.02.005","article-title":"In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus","volume":"18","author":"Zhang","year":"2020","journal-title":"J Integr Med"},{"issue":"1","key":"10.1016\/j.imu.2020.100458_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J Cheminf"},{"issue":"3","key":"10.1016\/j.imu.2020.100458_bib31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jcv.2005.03.005","article-title":"Expanding the frontiers of existing antiviral drugs: possible effects of HIV-1 protease inhibitors against SARS and avian influenza","volume":"34","author":"Savarino","year":"2005","journal-title":"J Clin Virol"},{"key":"10.1016\/j.imu.2020.100458_bib32","first-page":"400","article-title":"Unrevealing sequence and structural features of novel coronavirus using in silico approaches: the main protease as molecular target","volume":"19","author":"Ortega","year":"2020","journal-title":"EXCLI J"},{"issue":"4","key":"10.1016\/j.imu.2020.100458_bib33","first-page":"445","article-title":"Molecular investigation of SARS\u2013CoV-2 proteins and their interactions with antiviral drugs","volume":"12","author":"Calligari","year":"2020"},{"issue":"9","key":"10.1016\/j.imu.2020.100458_bib34","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/anie.200906696","article-title":"Induced\u2010fit binding of the macrocyclic noncovalent inhibitor TMC435 to its HCV NS3\/NS4A protease target","volume":"49","author":"Cummings","year":"2010","journal-title":"Angew Chem Int Ed"},{"issue":"6","key":"10.1016\/j.imu.2020.100458_bib35","article-title":"Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir\/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR","volume":"35","author":"Lim","year":"2020","journal-title":"J Kor Med Sci"},{"key":"10.1016\/j.imu.2020.100458_bib36","series-title":"Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation","author":"Xu","year":"2020"},{"issue":"46","key":"10.1016\/j.imu.2020.100458_bib37","doi-asserted-by":"crossref","first-page":"12997","DOI":"10.1073\/pnas.1601327113","article-title":"SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity","volume":"113","author":"Muramatsu","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.imu.2020.100458_bib38","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/CMR.11.4.614","article-title":"Protease inhibitors as antiviral agents","volume":"11","author":"Patick","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.imu.2020.100458_bib41","doi-asserted-by":"crossref","first-page":"117592","DOI":"10.1016\/j.lfs.2020.117592","article-title":"Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study","author":"Elfiky","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.imu.2020.100458_bib42","doi-asserted-by":"crossref","first-page":"117477","DOI":"10.1016\/j.lfs.2020.117477","article-title":"Anti-HCV, nucleotide inhibitors, repurposing against COVID-19","volume":"248","author":"Elfiky","year":"2020","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.imu.2020.100458_bib43","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1080\/07391102.2019.1597771","article-title":"Computational approach towards understanding structural and functional role of cytokinin oxidase\/dehydrogenase 2 (CKX2) in enhancing grain yield in rice plant","volume":"38","author":"Gouda","year":"2020","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.imu.2020.100458_bib44","doi-asserted-by":"crossref","first-page":"105960","DOI":"10.1016\/j.ijantimicag.2020.105960","article-title":"Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection","author":"Fantini","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.imu.2020.100458_bib45","first-page":"1","article-title":"Sialic acid receptors of viruses","volume":"367","author":"Matrosovich","year":"2015","journal-title":"Top Curr Chem"},{"key":"10.1016\/j.imu.2020.100458_bib46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Discov"},{"issue":"4","key":"10.1016\/j.imu.2020.100458_bib47","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0092-8674(93)90508-N","article-title":"bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death","volume":"74","author":"Boise","year":"1993","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.imu.2020.100458_bib48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000075701","article-title":"The role of c-jun protein in proliferation and apoptosis of the endometrium throughout the menstrual cycle","volume":"57","author":"Udou","year":"2004","journal-title":"Gynecol Obstet Invest"},{"issue":"6","key":"10.1016\/j.imu.2020.100458_bib49","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.imu.2020.100458_bib50","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/CCM.0b013e3182a2727d","article-title":"Adjuvant treatment with a mammalian target of rapamycin inhibitor, sirolimus, and steroids improves outcomes in patients with severe H1N1 pneumonia and acute respiratory failure","volume":"42","author":"Wang","year":"2014","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.imu.2020.100458_bib51","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.antiviral.2011.02.008","article-title":"Emodin inhibits current through SARS-associated coronavirus 3a protein","volume":"90","author":"Schwarz","year":"2011","journal-title":"Antivir Res"},{"issue":"2","key":"10.1016\/j.imu.2020.100458_bib52","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.antiviral.2006.04.014","article-title":"Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction","volume":"74","author":"Ho","year":"2007","journal-title":"Antivir Res"},{"issue":"4","key":"10.1016\/j.imu.2020.100458_bib53","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/095632020901900402","article-title":"Chang, and Chemotherapy, \"Thiopurine analogue inhibitors of severe acute respiratory syndrome-coronavirus papain-like protease, a deubiquitinating and deISGylating enzyme","volume":"19","author":"Chen","year":"2009","journal-title":"Antiviral Chem"},{"issue":"7798","key":"10.1016\/j.imu.2020.100458_bib54","first-page":"270","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"12","key":"10.1016\/j.imu.2020.100458_bib55","first-page":"1","article-title":"And disease, \"Activation of the c-Jun NH 2-terminal kinase pathway by coronavirus infectious bronchitis virus promotes apoptosis independently of c-Jun","volume":"8","author":"Fung","year":"2017","journal-title":"Cell death"},{"key":"10.1016\/j.imu.2020.100458_bib56","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13098-020-00537-z","article-title":"Melatonin: new insights on its therapeutic properties in diabetic complications","volume":"12","author":"Pourhanifeh","year":"2020","journal-title":"Diabetol Metab Syndrome"},{"issue":"5","key":"10.1016\/j.imu.2020.100458_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-020-0368-x","article-title":"Interaction between RAAS inhibitors and ACE2 in the context of COVID-19","volume":"17","author":"Mourad","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"10.1016\/j.imu.2020.100458_bib58","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity Map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.imu.2020.100458_bib59","author":"Yemen"},{"issue":"2","key":"10.1016\/j.imu.2020.100458_bib60","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00297-20","article-title":"Repurposing didanosine as a potential treatment for COVID-19 using single-cell RNA sequencing data","volume":"5","author":"Alakwaa","year":"2020","journal-title":"mSystems"},{"issue":"6","key":"10.1016\/j.imu.2020.100458_bib61","doi-asserted-by":"crossref","first-page":"928","DOI":"10.2165\/00003495-199652060-00014","article-title":"Didanosine","volume":"52","author":"Perry","year":"1996","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.imu.2020.100458_bib62","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0960-894X(01)00219-0","article-title":"Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and C-erbB-2","volume":"11","author":"Cockerill","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"10.1016\/j.imu.2020.100458_bib63","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1158\/0008-5472.CAN-03-3139","article-title":"Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications","volume":"64","author":"Rapisarda","year":"2004","journal-title":"Canc Res"},{"issue":"9","key":"10.1016\/j.imu.2020.100458_bib64","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.21873\/anticanres.13665","article-title":"Ro 90-7501 is a novel radiosensitizer for cervical cancer cells that inhibits ATM phosphorylation","volume":"39","author":"Tamari","year":"2019","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.imu.2020.100458_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0250-2","article-title":"Diagnosis of Alzheimer's disease utilizing amyloid and tau as fluid biomarkers","volume":"51","author":"Lee","year":"2019","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.imu.2020.100458_bib66","author":"Organization"},{"issue":"Database issue","key":"10.1016\/j.imu.2020.100458_bib67","doi-asserted-by":"crossref","first-page":"D306","DOI":"10.1093\/nar\/gkj105","article-title":"The PMDB protein model database","volume":"34","author":"Castrignano","year":"2006","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"10.1016\/j.imu.2020.100458_bib68","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"10.1016\/j.imu.2020.100458_bib69","doi-asserted-by":"crossref","first-page":"W252","DOI":"10.1093\/nar\/gku340","article-title":"SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information","volume":"42","author":"Biasini","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"10.1016\/j.imu.2020.100458_bib70","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","author":"The UniProt","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.imu.2020.100458_bib71","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/cpt.1864","article-title":"Chloroquine dosing recommendations for pediatric COVID-19 supported by modeling and simulation","volume":"108","author":"Verscheijden","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.imu.2020.100458_bib72","doi-asserted-by":"crossref","first-page":"137489","DOI":"10.1016\/j.cplett.2020.137489","article-title":"Identification of potential binders of the main protease 3CL(pro) of the COVID-19 via structure-based ligand design and molecular modeling","author":"Macchiagodena","year":"2020","journal-title":"Chem Phys Lett"},{"issue":"2","key":"10.1016\/j.imu.2020.100458_bib73","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/cpt.1856","article-title":"Optimizing hydroxychloroquine dosing for patients with COVID-19: an integrative modeling approach for effective drug repurposing","volume":"108","author":"Garcia-Cremades","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.imu.2020.100458_bib74","series-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review","author":"Sanders","year":"2020"}],"container-title":["Informatics in Medicine Unlocked"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352914820306080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352914820306080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:20:02Z","timestamp":1783941602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352914820306080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":72,"alternative-id":["S2352914820306080"],"URL":"https:\/\/doi.org\/10.1016\/j.imu.2020.100458","relation":{},"ISSN":["2352-9148"],"issn-type":[{"value":"2352-9148","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Applying computer simulations in battling with COVID-19, using pre-analyzed molecular and chemical data to face the pandemic","name":"articletitle","label":"Article Title"},{"value":"Informatics in Medicine Unlocked","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imu.2020.100458","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100458"}}